Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse

Immunotherapy is currently recognized as the fourth modality in cancer therapy. CTL can detect cancer cells via complexes involving human leukocyte antigen (HLA) class I molecules and peptides derived from tumor antigens, resulting in antigen‐specific cancer rejection. The peptides may be predicted...

Descripción completa

Detalles Bibliográficos
Autores principales: Charneau, Jimmy, Suzuki, Toshihiro, Shimomura, Manami, Fujinami, Norihiro, Mishima, Yuji, Hiranuka, Kazushi, Watanabe, Noriko, Yamada, Takashi, Nakamura, Norihiro, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990807/
https://www.ncbi.nlm.nih.gov/pubmed/35122353
http://dx.doi.org/10.1111/cas.15291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990807/
https://www.ncbi.nlm.nih.gov/pubmed/35122353
http://dx.doi.org/10.1111/cas.15291

Ejemplares similares